High-Dose Inhaled Corticosteroid Versus Long-Acting β-Agonist Addition in Asthma

被引:0
|
作者
Thomas, Mike [1 ]
Prince, David [1 ]
机构
[1] Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland
关键词
D O I
10.1378/chest.08-2947
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1404 / 1405
页数:2
相关论文
共 50 条
  • [1] Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma
    Israel, Elliot
    Roche, Nicolas
    Martin, Richard J.
    Colice, Gene
    Dorinsky, Paul M.
    Postma, Dirkje S.
    Guilbert, Theresa W.
    van Aalderen, Willem M. C.
    Grigg, Jonathan
    Hillyer, Elizabeth V.
    Burden, Anne
    von Ziegenweidt, Julie
    Thomas, Victoria
    Price, David B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (06) : 798 - 806
  • [2] High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: An observational study
    Thomas, Mike
    von Ziegenweidt, Julie
    Lee, Amanda J.
    Price, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 116 - 121
  • [3] Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations
    Gibson, Peter G.
    Powell, Heather
    Ducharme, Francine M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) : 344 - 350
  • [4] An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
    Alakeel, Yousif S.
    Khader, Esraa
    Altuwayli, Norah
    Alrammah, Shahad
    Abdel-Razaq, Wesam
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (03) : 300 - 305
  • [6] Evaluating Safety and Adverse Events Associated with Long-Acting β-Agonist in Combination Asthma Therapy Versus Inhaled Corticosteroid Alone
    Jose, Jaison
    Ishmael, Faoud
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (04): : 1158 - 1161
  • [7] Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical Implications
    Carlos A. Camargo
    Kourtney J. Davis
    Elizabeth B. Andrews
    David A. Stempel
    Michael Schatz
    Clinical Drug Investigation, 2016, 36 : 993 - 999
  • [8] Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical Implications
    Camargo, Carlos A., Jr.
    Davis, Kourtney J.
    Andrews, Elizabeth B.
    Stempel, David A.
    Schatz, Michael
    CLINICAL DRUG INVESTIGATION, 2016, 36 (12) : 993 - 999
  • [9] APPROPRIATE USE OF INHALED CORTICOSTEROID AND LONG-ACTING β-AGONIST COMBINATION THERAPY AMONG ASTHMA PATIENTS
    Blanchette, C. M.
    Culler, S.
    Gutierrez, B.
    VALUE IN HEALTH, 2009, 12 (03) : A128 - A128
  • [10] Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations
    Pedersen, Soren
    O'Byrne, Paul M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (05) : 1280 - 1281